Spearheaded and developed thought leaders and advocates for
nuclear medicine at North Shore Hospital, Long Island Jewish Hospital, and New York Hospital Medical Center.
Dr. Mark Peterson graduated from the University of Minnesota in 1976, moved to NYC to do an internship and medical residency at The Animal Medical Center, and then completed a post-doctoral fellowship in endocrinology and
nuclear medicine at The New York Hospital - Cornell Medical Center and the AMC.Following his training, Mark stayed on as head endocrinologist at the AMC for over 30 years.
Dr. Peterson served as head of endocrinology and
nuclear medicine at The Animal Medical Center for over 30 years.
He then finished a post-doctoral fellowship in both endocrinology and
nuclear medicine at The New York Hospital - Cornell Medical Center.
Clinical Professor in the Department of Radiology and
Nuclear Medicine at Albert Einstein College of Medicine and ketogenic cancer researcher Dr. Eugene Fine is our special 2016 Metabolic Therapeutics Conference guest speaker featured in Episode 1185...
This project was carried out in the department of
nuclear medicine at the Klinikum rechts der Isar in Munich.
It represents a great reward for the entire team and will strongly motivate our group,» said Alexander Drzezga, MD, of the Department of
Nuclear Medicine at the University Hospital of Cologne in Cologne, Germany.
As part of the celebration, Abass Alavi, M.D., Chief of the Division of
Nuclear Medicine at the University of Pennsylvania, gave a talk titled, «Unparalleled Contributions of FDG - PET to Medicine.»
«Given the link between 11C - sarcosine cell uptake and PAT transport, the study provides first evidence that PAT expression can be elevated in prostate cancer,» explains Morand Piert, MD, professor of radiology, Division of
Nuclear Medicine at the University of Michigan, Ann Arbor, Michigan.
Researchers at the University Department of Radiology and
Nuclear Medicine at the MedUni Vienna have now demonstrated by means of a meta - analysis of functional image data that increased activations in the involuntary attention system in the brain are responsible for these disorders in MS patients.
Not exact matches
Spending time in the «
Nuclear Medicine Unit»
at Cedars has become all too familiar and taking a daily dose of a thyroid replacement hormone is my new normal.
1) Repeal the Triborough Amendment; 2) State pick - up of Medicaid costs from counties; 3) Roll - back of Medicaid entitlements / coverages to median national levels; 4) Major reform of SEQR process which blocks projects Upstate; 5) Repeal NY's participation in RGGI; 6) Cut 50 percent of staff
at DOE, DOH, DEC in order to let the other half do their jobs, which means serving the people instead of feeding the bureaucratic monster; 7) Support expansion of
nuclear plants
at Oswego, construction of new plants elsewhere; 8) Tort reform to allow doctors to practice
medicine, instead of fleeing NY; 9) Use the bully pulpit to support natural gas drilling and tell the envirowackos to grow up.
Patients with colon and rectal cancer have somatic insertions of mitochondrial DNA into the
nuclear genomes of the cancer cells, University of Alabama
at Birmingham researchers report in the journal Genome
Medicine.
BACKGROUND: The origins of
nuclear medicine involve
at least a dozen scientists working on different aspects of the technology over a century, culminating in a surge of diagnostic machines in the 1980s and»90s.
And here
at TRIUMF, I work on
nuclear physics accelerators and the cyclotron, which is used for materials science and
nuclear medicine.
Because it looks for a process, not a part,
nuclear medicine is particularly good
at showing whether or not cancer has metastasized to a distant site, such as from the lungs to the brain.
A novel molecular imaging technique could be the key to understanding how best to treat these and other devastating diseases, according to a recent study presented
at the 2015 Annual Meeting of the Society of
Nuclear Medicine and Molecular Imaging (SNMMI).
Scientists are taking medical imaging research and drug discovery to a new level by developing a molecular imaging system that combines several advanced technologies for all - in - one imaging of both tissue models and live subjects, say presenters
at the 2015 Annual Meeting of the Society of
Nuclear Medicine and Molecular Imaging (SNMMI).
Bigger isn't always better, especially when it comes to a new and surprisingly portable molecular imaging system that combines optical imaging
at the surface level and scintigraphy, which captures the physiological function of what lies beneath, announced developers
at the 2016 Annual Meeting of the Society of
Nuclear Medicine and Molecular Imaging (SNMMI).
A recently developed drug was significantly better
at detecting recurring prostate cancer in early stages, in research published in the August 2015 issue of The Journal of
Nuclear Medicine.
A relatively new biomarker called prostate - specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled
at the 2015 annual meeting of the Society of
Nuclear Medicine and Molecular Imaging (SNMMI).
«Radioimmunotherapy not only worked against these cancers but, in addition, the radioactivity was confined entirely to the tumor masses, leaving healthy tissues undamaged,» said senior study co-author Ekaterina Dadachova, an associate professor of
nuclear medicine and of microbiology and immunology
at Einstein.
An international team of researchers from NASA Ames Research Center, Environmental and Radiation Health Sciences Directorate
at Health Canada, Oxford University, Canadian
Nuclear Laboratories, Belgian
Nuclear Research Centre, Insilico
Medicine, the Biogerontology Research Center, Boston University, Johns Hopkins University, University of Lethbridge, Ghent University, Center for Healthy Aging and many others have published a roadmap toward enhancing human radioresistance for space exploration and colonization in the peer - reviewed journal Oncotarget.
Researchers from the University of Seville
at the Andalusian Centre for Molecular Biology and Regenerative
Medicine (Centro Andaluz de Biología Molecular y Medicina Regenerativa — Cabimer) have discovered that in eukaryotic cells the proximity of the genes to the
nuclear pores, which are found in the
nuclear membrane, contributes to maintaining the integrity of the genome.
The test results were presented
at the 2016 Society of
Nuclear Medicine and Molecular Imaging Annual Meeting in San Diego on June 13.
Used in conjunction with mammography, imaging based on
nuclear medicine is currently being used as a successful secondary screening alongside mammography to reduce the number of false positive results in women with dense breasts and
at higher risk for developing breast cancer.
Researchers
at the 2016 Annual Meeting of the Society of
Nuclear Medicine and Molecular Imaging (SNMMI) are presenting a molecular imaging technique that allows oncologists to set patients» radiotherapy doses right
at that critical limit of delivering the most powerful kill to neuroendocrine tumors (NETs) while protecting vulnerable vital organs.
An investigational molecular imaging technique could be the key to finding the elusive primary tumor, say presenters
at the 2015 Annual Meeting of the Society of
Nuclear Medicine and Molecular Imaging (SNMMI).
In the featured translational article in the August issue of The Journal of
Nuclear Medicine, researchers
at the University of Michigan demonstrate the potential of a new PET tracer, Carbon - 11 labeled sarcosine (11C - sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.
San Diego, Calif. (Embargoed until 6 PM on Tuesday, June 14)-- Bigger isn't always better, especially when it comes to a new and surprisingly portable molecular imaging system that combines optical imaging
at the surface level and scintigraphy, which captures the physiological function of what lies beneath, announced developers
at the 2016 Annual Meeting of the Society of
Nuclear Medicine and Molecular Imaging (SNMMI).
Baltimore, Md. (Embargoed until 12:30 pm EDT on Monday, June 8)-- A relatively new biomarker called prostate - specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled
at the 2015 Annual Meeting of the Society of
Nuclear Medicine and Molecular Imaging (SNMMI).
This multimodal study shows significant correlation between increased tau and decreased metabolic activity in the brain — a clear sign of neurodegeneration — reveal researchers
at the 2016 Annual Meeting of the Society of
Nuclear Medicine and Molecular Imaging (SNMMI).
A pioneer in the diagnostic uses of radiation and the development and testing of radiotracers in the early days of
nuclear medicine, Robert N. Beck, professor emeritus in the Department of Radiology
at the University of Chicago, died
at the University of Chicago Medical Center on August 6, 2008, from myelodysplasia, a form of leukemia.
* Two winners will be selected
at the conclusion of
Nuclear Medicine and Molecular Imaging Week.
Selection of SNMMI Fellows will be based on documented excellence in volunteer service to the society and
at least one of the additional three areas: excellence in scientific discovery and innovation; educational efforts in
nuclear medicine and molecular imaging; or clinical practice of
nuclear medicine and molecular imaging.
SNMMI launched a new fellowship program
at the Sunday plenary to recognize distinguished service to SNMMI, as well as exceptional achievement in the field of
nuclear medicine and molecular imaging.
Reston, Va. (June 15, 2016)-- More than 5,700 physicians, technologists, scientists and exhibitors gathered
at the Society of
Nuclear Medicine and Molecular Imaging's (SNMMI) 2016 Annual Meeting, held June 11 - 15 in San Diego, Calif..
At that time both organizations agreed to work towards the creation and implementation of a Sino - American Conference on
Nuclear Medicine.
Alain Destexhe, Research Director of Unité de Neurosciences CNRS, Gif - sur - Yvette, France Bruno Weber, Professor of Multimodal Experimental Imaging, Universitaet Zuerich, Switzerland Carmen Gruber Traub, Fraunhofer, Germany Costas Kiparissides, Certh, Greece Cyril Poupon, Head of the
Nuclear Magnetic Resonance Imaging and Spectroscopy unit of NeuroSpin, University Paris Saclay, Gif - sur - Yvette, France David Boas, Professor of Radiology
at Massachusetts General Hospital, Harvard Medical School, University of Pennsylvania Hanchuan Peng, Associate Investigator
at Allen Brain Institute, Seattle, US Huib Manswelder, Head of Department of Integrative Neurophysiology Center for Neurogenomics and Cognitive Research, VU University, Amsterdam Jan G. Bjaalie, Head of Neuroinformatics division, Institute of Basic Medical Sciences, University of Oslo, Norway Jean - François Mangin, Research Director Neuroimaging
at CEA, Gif - sur - Yvette, France Jordi Mones, Institut de la Macula y la Retina, Barcelona, Spain Jurgen Popp, Scientific Director of the Leibniz Institute of Photonic Technology, Jena, Germany Katharina Zimmermann, Hochshule, Germany Katrin Amunts, Director of the Institute Structural and functional organisation of the brain, Forschungszentrum Juelich, Germany Leslie M. Loew, Professor
at University of Connecticut Health Center, Connecticut, US Marc - Oliver Gewaltig, Section Manager of Neurorobotics, Simulation Neuroscience Division - Ecole Polytechnique fédérale de Lausanne (EPFL), Geneve, Switzerland Markus Axer, Head of Fiber architecture group, Institute of Neuroscience and
Medicine (INM - 1)
at Forschungszentrum Juelich, Germany Mickey Scheinowitz, Head of Regenerative Therapy Department of Biomedical Engineering and Neufeld Cardiac Research Institute, Tel - Aviv University, Israel Pablo Loza, Institute of Photonic Sciences, Castelldefels, Spain Patrick Hof, Mount Sinai Hospital, New York, US Paul Tiesinga, Professor
at Faculty of Science, Radboud University, Nijmegen, Netherlands Silvestro Micera, Director of the Translational Neural Engineering (TNE) Laboratory, and Associate Professor
at the EPFL School of Engineering and the Centre for Neuroprosthetics Timo Dicksheid, Group Leader of Big Data Analytics, Institute Structural and functional organisation of the brain, Forschungszentrum Juelich, Germany Trygve Leergaard, Professor of Neural Systems, Institute of Basic Medical Sciences, University of Oslo, Norway Viktor Jirsa, Director of the Institute de Neurosciences des Systèmes and Director of Research
at the CNRS, Marseille, France
The CaIC strives to ensure that continuing education sessions
at SNMMI meetings fulfill the needs and interests of its members and others in the
nuclear medicine community.
The latest research, clinical investigations, basic science reports, and more are
at your fingertips, thanks to SNMMI's leading journals and publications, including the esteemed Journal of
Nuclear Medicine (JNM).
Visit the Journal of
Nuclear Medicine (JNM) website
at jnm.snmjournals.org to search 2017 full - text abstracts online!
Ken Czerwinski (Chemistry and Biochemistry) has accepted an invitation from the director of the
Nuclear and Radiation Studies Board
at the National Academies of Sciences, Engineering, and
Medicine to serve as an expert on a study mandated by Congress on the treatment of low - level radioactive waste
at the Hanford site in Washington state...
Resulting from collaboration between experts in
nuclear medicine, medical oncology, and surgical oncology, this book provides balanced, relevant information accessible to clinicians
at all levels?ultimately enhancing patient care.
* Based on the findings of a survey conducted
at 13 premier pediatric hospitals in North America indicating administered radiopharmaceutical activities in children varied greatly, a workgroup was established representing the Society of
Nuclear Medicine and Molecular Imaging (SNMMI) through the Pediatric Council, the Society for Pediatric Radiology and the Amercian College of Radiology (ACR).
The Brain Imaging Center
at the Academic Medical Center (BIC - AMC) in Amsterdam is a collaboration between the Departments of Psychiatry, Radiology,
Nuclear Medicine, and Neurology.
I'm a
nuclear medicine physician at Albert Einstein College of Medicine
medicine physician
at Albert Einstein College of
MedicineMedicine in NYC.
Professor of radiology (
nuclear medicine) at the Albert Einstein College of Medicine, ketogenic diet and cancer res
medicine)
at the Albert Einstein College of
Medicine, ketogenic diet and cancer res
Medicine, ketogenic diet and cancer researcher.
The areas of specialty available
at VCVREC are Acupuncture, Cardiology, Clinical Pathology, Emergency
Medicine, Internal
Medicine,
Nuclear Medicine, Oncology, Ophthalmology, and Surgery.
Our
Nuclear Medicine Department
at Valley Central Veterinary Referral and Emergency Center is designed exclusively for the treatment of cats with hyperthyroidism.